Recombinant Human GLO2 Protein ，GST

GLO2, or glyoxalase 2, is an enzyme that plays a crucial role in the detoxification of reactive aldehydes, specifically methylglyoxal, which is a byproduct of glycolysis and is known to cause cellular damage. The significance of GLO2 in various biological processes, including cellular response to oxidative stress and its implications in diseases such as diabetes, neurodegeneration, and cancer, has garnered increasing research interest. In recent years, studies have highlighted the potential of GLO2 as a therapeutic target, emphasizing the need for a deeper understanding of its structure and function. The recombinant expression of GLO2 allows for the study of its enzymatic activity, interactions, and potential inhibitors, providing insights into its role in cellular metabolism and pathophysiology. Moreover, the ability to produce large quantities of GLO2 through recombinant techniques facilitates high-throughput screening of compounds that could modulate its activity, thus opening avenues for drug development. By elucidating the mechanism of action of GLO2 and its involvement in disease processes, researchers aim to identify novel strategies for therapeutic intervention, making it a promising candidate for further investigation in the context of metabolic disorders and cancer therapy.